Product Code: 2890
The U.S. medical marijuana market size is poised to witness substantial growth over the forecast years 2022 to 2030. Increasing government efforts to legalize marijuana for medical purposes has helped authorize product consumption across more than two-thirds of U.S. States. Agencies like the U.S. Food and Drug Administration (FDA) have permitted medical marijuana-based treatment for two rare and severe forms of epilepsy, namely Lennox-Gastaut syndrome and Dravet syndrome.
Growing efforts to determine the efficacy of cannabis-infused medical supplements to aid cancer patients or individuals with other neurological conditions will positively affect the industry outlook. In April 2022, the U.S. House of Representatives passed a bipartisan marijuana research bill, allowing scientists access to marijuana at dispensaries of legal cannabis states. The Marijuana Opportunity Reinvestment & Expungement Act is expected to boost R&D, access, and further development of novel medical marijuana products.
The U.S. medical marijuana market is categorized into the application, route of administration, distribution channel, and region.
With respect to application, the industry is bifurcated into pain management, seizures, anorexia, muscle spasms, and nausea. The market share from the seizures segment exceeded USD 305 million in 2021.
Medical marijuana is widely used to treat seizures, which occur on uncontrolled electrical disturbances in the human brain. Epilepsy is one such seizure-inducing health condition that affects nearly 3.4 million people in the U.S. The rising prevalence of seizures in the U.S. will fuel demand for medical marijuana.
Based on the route of administration, the U.S. medical marijuana market is fragmented into oral, inhalation, and topical. Among these, the market share from the inhalation segment is projected to exhibit over 10% CAGR between 2022-2030. Administration of medical marijuana with the help of inhalers allows the drug to reach target organs and thus requires a lesser dosage. A medical marijuana inhaler delivers accurate quantities of THC and CBD to provide relief from discomfort, and tension.
In terms of distribution channel, the industry is classified into online, and dispensaries. Among these, the online segment accounted for over 39.9% share of the U.S. medical marijuana market in 2021. Rise in the number of online drug stores or pharmacies as a result of growing e-commerce trends enhance access to medical marijuana products.
A large number of manufacturers and suppliers are developing online websites to boost sales and provide timely delivery services, and convenience of shopping to consumers. The availability of a wide variety of products will drive customer engagement across online distribution channels.
West South Central U.S. medical marijuana market size was worth more than USD 1 billion in 2021. West South Central states in the U.S. have witnessed a surge in clinical research for the use of marijuana for medical reasons with government backing. In July 2022, the University of Louisiana Monroe School of Pharmacy secured approval from the Louisiana Senate to conduct cannabis testing and research.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definition
- 1.2 Base estimates & working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 U.S. medical marijuana industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Application trends
- 2.1.3 Route of administration trends
- 2.1.4 Distribution channel trends
- 2.1.5 Zonal trends
Chapter 3 US Medical Marijuana Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Increasing application of marijuana for a myriad of medical conditions and symptoms
- 3.3.1.2 Growing demand for medical marijuana legalization in several countries
- 3.3.1.3 Rising number of R&D and clinical trial activities
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Few side effects might hinder the market growth
- 3.3.2.2 Difficulty in medical marijuana business banking
- 3.4 Growth potential analysis
- 3.4.1 By application
- 3.4.2 By route of administration
- 3.4.3 By distribution channel
- 3.5 COVID-19 impact analysis
- 3.6 Regulatory landscape & guidelines
- 3.6.1 Alaska
- 3.6.2 Arizona
- 3.6.3 Arkansas
- 3.6.4 California
- 3.6.5 Colorado
- 3.6.6 Connecticut
- 3.6.7 Delaware
- 3.6.8 Florida
- 3.6.9 Hawaii
- 3.6.10 Illinois
- 3.6.11 Louisiana
- 3.6.12 Maine
- 3.6.13 Maryland
- 3.6.14 Massachusetts
- 3.6.15 Michigan
- 3.6.16 Minnesota
- 3.6.17 Montana
- 3.6.18 Missouri
- 3.6.19 Nevada
- 3.6.20 New Hampshire
- 3.6.21 New Jersey
- 3.6.22 New Mexico
- 3.6.23 New York
- 3.6.24 North Dakota
- 3.6.25 Pennsylvania
- 3.6.26 Ohio
- 3.6.27 Oklahoma
- 3.6.28 Oregon
- 3.6.29 Rhode Island
- 3.6.30 South Dakota
- 3.6.31 Utah
- 3.6.32 Virginia
- 3.6.33 Vermont
- 3.6.34 West Virginia
- 3.6.35 Washington
- 3.6.36 Washington D.C.
- 3.7 Value chain analysis
- 3.8 Legal requirement for distribution of medical marijuana
- 3.9 Porter's analysis
- 3.10 Competitive landscape, 2021
- 3.10.1 Company matrix analysis, 2021
- 3.11 PESTEL analysis
Chapter 4 US Medical Marijuana Market, By Application
- 4.1 Key segment trends
- 4.2 Pain Management
- 4.2.1 Market size, by zones, 2017 - 2030 (USD Million)
- 4.2.2 Neuropathic pain
- 4.2.2.1 Market size, by zones, 2017 - 2030 (USD Million)
- 4.2.3 Cancer pain
- 4.2.3.1 Market size, by zones, 2017 - 2030 (USD Million)
- 4.2.4 Others
- 4.2.4.1 Market size, by zones, 2017 - 2030 (USD Million)
- 4.3 Muscle spasms
- 4.3.1 Market size, by zones, 2017 - 2030 (USD Million)
- 4.4 Nausea
- 4.4.1 Market size, by zones, 2017 - 2030 (USD Million)
- 4.5 Anorexia
- 4.5.1 Market size, by zones, 2017 - 2030 (USD Million)
- 4.6 Seizures
- 4.6.1 Market size, by zones, 2017 - 2030 (USD Million)
- 4.7 Others
- 4.7.1 Market size, by zones, 2017 - 2030 (USD Million)
Chapter 5 US Medical Marijuana Market, By Route of Administration
- 5.1 Key segment trends
- 5.2 Inhalation
- 5.2.1 Market size, by zones, 2017 - 2030 (USD Million)
- 5.3 Oral
- 5.3.1 Market size, by zones, 2017 - 2030 (USD Million)
- 5.4 Topical
- 5.4.1 Market size, by zones, 2017 - 2030 (USD Million)
Chapter 6 US Medical Marijuana Market, By Distribution Channel
- 6.1 Key segment trends
- 6.2 Dispensaries
- 6.2.1 Market size, by zones, 2017 - 2030 (USD Million)
- 6.3 Online
- 6.3.1 Market size, by zones, 2017 - 2030 (USD Million)
Chapter 7 US Medical Marijuana Market, By Zone
- 7.1 Key zonal trends
- 7.2 North East
- 7.2.1 Market size, by states, 2017 - 2030 (USD Million)
- 7.2.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.3 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.2.5 Connecticut
- 7.2.5.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.2.6 Maine
- 7.2.6.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.2.7 Massachusetts
- 7.2.7.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.2.8 New Hampshire
- 7.2.8.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.2.9 Rhode Island
- 7.2.9.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.2.10 Vermont
- 7.2.10.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.10.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.10.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.2.11 New Jersey
- 7.2.11.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.11.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.11.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.11.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.2.12 New York
- 7.2.12.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.12.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.12.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.12.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.2.13 Pennsylvania
- 7.2.13.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.13.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.2.13.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.2.13.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.3 East North Central
- 7.3.1 Market size, by states, 2017 - 2030 (USD Million)
- 7.3.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.3.3 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.3.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.3.5 Illinois
- 7.3.5.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.3.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.3.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.3.6 Michigan
- 7.3.6.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.3.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.3.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.3.7 Ohio
- 7.3.7.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.3.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.3.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.4 South Atlantic
- 7.4.1 Market size, by states, 2017 - 2030 (USD Million)
- 7.4.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.4.3 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.4.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.4.5 Delaware
- 7.4.5.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.4.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.4.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.4.6 Florida
- 7.4.6.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.4.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.4.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.4.7 Maryland
- 7.4.7.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.4.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.4.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.4.8 Washington D.C.
- 7.4.8.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.4.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.4.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.4.9 Virginia
- 7.4.9.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.4.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.4.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.4.10 West Virginia
- 7.4.10.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.10.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.4.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.4.10.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.5 West North Central
- 7.5.1 Market size, by states, 2017 - 2030 (USD Million)
- 7.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.5.3 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.5.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.5.5 Minnesota
- 7.5.5.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.5.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.5.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.5.6 Missouri
- 7.5.6.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.5.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.5.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.5.7 North Dakota
- 7.5.7.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.5.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.5.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.5.8 South Dakota
- 7.5.8.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.5.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.5.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.6 Pacific Central
- 7.6.1 Market size, by states, 2017 - 2030 (USD Million)
- 7.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.6.3 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.6.5 California
- 7.6.5.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.6.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.6.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.6.6 Alaska
- 7.6.6.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.6.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.6.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.6.7 Hawaii
- 7.6.7.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.6.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.6.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.6.8 Oregon
- 7.6.8.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.6.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.6.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.6.9 Washington
- 7.6.9.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.6.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.6.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.7 Mountain States
- 7.7.1 Market size, by states, 2017 - 2030 (USD Million)
- 7.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.7.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.7.3 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.7.5 Arizona
- 7.7.5.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.7.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.7.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.7.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.7.6 Colorado
- 7.7.6.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.7.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.7.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.7.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.7.7 Nevada
- 7.7.7.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.7.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.7.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.7.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.7.8 New Mexico
- 7.7.8.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.7.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.7.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.7.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.7.9 Montana
- 7.7.9.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.7.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.7.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.7.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.7.10 Utah
- 7.7.10.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.7.10.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.7.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.7.10.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.8 West South Central
- 7.8.1 Market size, by states, 2017 - 2030 (USD Million)
- 7.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.8.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.8.3 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.8.5 Arkansas
- 7.8.5.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.8.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.8.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.8.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.8.6 Oklahoma
- 7.8.6.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.8.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.8.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.8.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 7.8.7 Louisiana
- 7.8.7.1 Market size, by application, 2017 - 2030 (USD Million)
- 7.8.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
- 7.8.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
- 7.8.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
- 8.1 Competitive dashboard
- 8.2 Canopy Growth Corporation
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Service landscape
- 8.2.4 SWOT analysis
- 8.3 Aurora Cannabis, Inc.
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Service landscape
- 8.3.4 SWOT analysis
- 8.4 GW Pharmaceuticals
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Service landscape
- 8.4.4 SWOT analysis
- 8.5 Medical Marijuana, Inc.
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Service landscape
- 8.5.4 Strategic outlook
- 8.5.5 SWOT analysis
- 8.6 Cannabis Sativa, Inc.
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Service landscape
- 8.6.4 Strategic outlook
- 8.6.5 SWOT analysis
- 8.7 Emerald Health Therapeutics Inc.
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Service landscape
- 8.7.4 SWOT analysis
- 8.8 The Cronos Group Inc.
- 8.8.1 Business overview
- 8.8.2 Financial data
- 8.8.3 Service landscape
- 8.8.4 SWOT analysis
- 8.9 Tilray
- 8.9.1 Business overview
- 8.9.2 Financial data
- 8.9.3 Service landscape
- 8.9.4 SWOT analysis
- 8.10 Lexaria Bioscience Corp
- 8.10.1 Business overview
- 8.10.2 Financial data
- 8.10.3 Service landscape
- 8.10.4 SWOT analysis
- 8.11 Curaleaf
- 8.11.1 Business overview
- 8.11.2 Financial data
- 8.11.3 Service landscape
- 8.11.4 Strategic outlook
- 8.11.5 SWOT analysis
- 8.12 Green Roads
- 8.12.1 Business overview
- 8.12.2 Financial data
- 8.12.3 Service landscape
- 8.12.4 Strategic outlook
- 8.12.5 SWOT analysis
- 8.13 CHARLOTTE'S WEB
- 8.13.1 Business overview
- 8.13.2 Financial data
- 8.13.3 Service landscape
- 8.13.4 Strategic outlook
- 8.13.5 SWOT analysis
- 8.14 Gaia Herbs
- 8.14.1 Business overview
- 8.14.2 Financial data
- 8.14.3 Service landscape
- 8.14.4 Strategic outlook
- 8.14.5 SWOT analysis
- 8.15 Folium Biosciences
- 8.15.1 Business overview
- 8.15.2 Financial data
- 8.15.3 Service landscape
- 8.15.4 Strategic outlook
- 8.15.5 SWOT analysis